Hansoh Pharmaceutical Group Co Ltd - Cost of Goods Sold Including Depreciation and Amortization
Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.
The item "Cost-of-Goods-Sold-Including-Depreciation-and-Amortization" stands at 1.18 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the highest value at least since 03/31/2017, the period currently displayed.'
Regarding the One-Year-Change of the series, the current value constitutes an increase of 18.88 percent compared to the value the year prior.
The 1 year change in percent is 18.88.
The 3 year change in percent is 37.94.
The 5 year change in percent is 80.42.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +185.72%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 06/30/2025, is 0.0%.
Cost of Goods Sold Including Depreciation and Amortization for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | Eli Lilly and Company - Cost of Goods Sold Including Depreciation and Amortization | 905,699,262,464.00 |
 | Johnson & Johnson - Cost of Goods Sold Including Depreciation and Amortization | 486,508,953,600.00 |
 | AbbVie Inc - Cost of Goods Sold Including Depreciation and Amortization | 399,570,305,024.00 |
 | Roche Holding AG - Cost of Goods Sold Including Depreciation and Amortization | 317,433,206,677.55 |
 | AstraZeneca PLC - Cost of Goods Sold Including Depreciation and Amortization | 280,205,508,085.11 |